C2I is home to over 25 biotechnology startups with the capability to provide more than 50 life science entrepreneurs a place to call home. Our residents have created over 100 highly skilled jobs and C2I had helped make an economic impact of 450M+ in funds raised in the Commonwealth.
SynerK, Inc. is a biotechnology company engaged in the development of life changing treatment in the areas of cancer, inflammatory and rare diseases. SynerK utilizes antisense technology to specifically silence genes that are responsible for various diseases.
Sequence with Accuracy SeqLL is an industry leading DNA and RNA sequencing service provider, particularly for single molecule sequencing data.
CreaGen Inc. is a premier chemistry-based drug discovery service company that provides cost-effective, high quality discovery research services to biotech and pharmaceutical companies.
MIT Martin Trust
The Martin Trust Center for MIT Entrepreneurship provides the expertise, support, and connections MIT students need to become effective entrepreneurs.
Rubix Strategies is a technical business think tank firm that delivers innovative solutions [From Research & Development to initial Product Life-Cycle launch] to industries of the technical discipline.
JA Bio Inc.
JA Bio Inc. is a startup bio-tech company located at Cambridge in Massachusetts. We are focusing on anti-cancer cell immune therapeutics discovery and development.
ConsortiaTX, Inc. is a seed stage, pre-clinical bio-therapeutics company that emerged from research laboratories at Brigham & Women’s Hospital and Children’s Hospital in Boston. The company’s intellectual property around food allergies and the human gut microbiome is based on the work of Lynn Bry, M.D., Ph.D., Georg Gerber, M.D., Ph.D. (both at BWH), and Talal Chatilla, Ph.D. (at CHB) and others.
Javelin Biotech provides an integrative preclinical drug testing platform for pharmaceutical and biotech industries by merging organ-on-chip (OoC) technologies and computational biology/AI to optimize lead selection and clinical trial design. Human OoC technologies culture human tissues in microphysiological environments enabling the most human relevant in vitro drug tests. The preclinical safety, efficacy, and pharmacokinetics data are translated to predictions of how drugs perform in humans.
Velum Inc. is a new start-up company that is focused on developing therapies for rare, orphan diseases.
Real Isolates investigates novel processing protocols for natural products. Our research is aimed at optimizing the extraction and purification of medicinal natural products for pharmaceutical-grade purity and sustainable efficiency.